Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom
-
- STATUS
- Recruiting
-
- participants needed
- 700
-
- sponsor
- Sanofi Pasteur, a Sanofi Company
Summary
The primary objective of the study is to demonstrate the non-inferiority of the antibody responses to meningococcal serogroups A, C, W, and Y when MenACYW conjugate vaccine is administered concomitantly with a licensed meningococcal group B vaccine in the second year of life compared to when MenACYW conjugate vaccine is given alone The secondary objective is to describe the antibody geometric mean titers (GMTs) of meningococcal serogroups A, C, W, and Y when MenACYW conjugate vaccine is administered concomitantly with a licensed meningococcal group B vaccine in the second year of life and when MenACYW conjugate vaccine is given alone
Description
Study duration per participant will be approximately 11 to 12 months
Details
| Condition | Meningococcal infection |
|---|---|
| Age | 1years - 1years |
| Treatment | Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine MenACYW conjugate vaccine, Meningococcal group B vaccine, Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated) vaccine, Human rotavirus RIX4414 strain vaccine, Pneumococcal 13-valent polysaccharide conjugate vaccine |
| Clinical Study Identifier | NCT03632720 |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Last Modified on | 28 March 2023 |
Similar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.